Both in Pharmaceuticals
ADC Therapeutics SA vs Upstream Bio
Over the past year ADCT returned −65.7% and UPB returned −86.8%; their daily moves had a correlation of 0.10.
ADCT −65.7% UPB −86.8%Growth of $1, one year, split-adjusted
| Metric | ADCT | UPB |
|---|---|---|
| Price | $1.53 | $3.41 |
| Market cap | $195.3M | $186.8M |
| Today | +2.68% | +4.28% |
| 1 month | +41.7% | −32.3% |
| 6 months | −60.1% | −63.7% |
| Year to date | −56.7% | −87.4% |
| 1 year | −66.8% | −85.9% |
| Revenue growth (YoY) | +2.2% | −17.5% |
| Gross margin | 87.8% | 100.0% |
| Net margin | −86.1% | −5136.1% |
| P/E (TTM) | — | — |
| Price / sales | 2.5× | 59.1× |
| Net cash | $102.5M | $261.3M |
| Dividend yield | — | — |
| Volatility (60d) | 100.1% | 83.4% |
| Short % of float | 6.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).